CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
Nippon Sanso logs decent quarters thanks primarily to operational improvements but also a bright spot in European performance ...
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
In a regulatory filing, Vertex Pharmaceuticals (VRTX) chief scientific officer David Altshuler disclosed the sale of 3,231 common shares of the ...
Explore the interplay of light and shadow in architecture, enhancing perception, atmosphere, and emotional responses.
Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...
Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...
Analysts may not have crystal balls, but they’re pretty bullish on Vertex’s 2028 outlook, despite its rocky stock performance ...
The fact that this simple and then-unprecedented innovation is still in use on modern watches in a more or less unchanged form confirms its importance ... with just straight lines and right angles. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback